NLTX

Neoleukin Therapeutics (NLTX)

Neoleukin Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NLTX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/08/10	05:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/08/09	20:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/08/07	20:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/06/21	21:32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/06/19	03:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/06/18	03:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/06/18	03:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/06/18	03:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/06/18	03:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/06/18	03:35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/06/03	20:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/05/11	05:14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/05/10	20:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/05/07	19:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/04/27	03:34	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/04/27	03:33	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/04/27	03:33	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/04/23	05:44	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/04/03	04:43	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/03/19	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/03/19	05:04	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/03/15	09:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/03/15	09:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/03/15	09:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/03/08	06:29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/03/05	08:20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/03/04	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/02/22	06:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/02/21	06:16	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:NLTX	Neoleukin Therapeutics Inc
2024/02/15	08:05	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:NLTX	Neoleukin Therapeutics Inc